Sino Biopharmaceutical (Sino Biopharmaceutical) Price-to-Tangible-Book : 1.57 (As of Apr. 25, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Price-to-Tangible-Book?

As of today (2024-04-25), Sino Biopharmaceutical's share price is $0.31495. Sino Biopharmaceutical's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $0.20. Hence, Sino Biopharmaceutical's Price to Tangible Book Ratio of today is 1.57.

The historical rank and industry rank for Sino Biopharmaceutical's Price-to-Tangible-Book or its related term are showing as below:

SBMFF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.66 Med: 5.61 Max: 16.5
Current: 1.66

During the past 13 years, Sino Biopharmaceutical's highest Price to Tangible Book Ratio was 16.50. The lowest was 1.66. And the median was 5.61.

SBMFF's Price-to-Tangible-Book is ranked better than
68.39% of 1218 companies
in the Biotechnology industry
Industry Median: 2.69 vs SBMFF: 1.66

A closely related ratio is called PB Ratio. As of today, Sino Biopharmaceutical's share price is $0.31495. Sino Biopharmaceutical's Book Value per Sharefor the quarter that ended in Jun. 2023 was $0.22. Hence, Sino Biopharmaceutical's P/B Ratio of today is 1.41.

Sino Biopharmaceutical Price-to-Tangible-Book Historical Data

The historical data trend for Sino Biopharmaceutical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Price-to-Tangible-Book Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

10.54

7.66

2.79

2.76

2.05

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.79	2.58	2.76	1.95	2.05

Competitive Comparison of Sino Biopharmaceutical's Price-to-Tangible-Book

For the Biotechnology subindustry, Sino Biopharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Price-to-Tangible-Book falls into.

Sino Biopharmaceutical Price-to-Tangible-Book Calculation

Sino Biopharmaceutical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	0.31495	/	0.201
	=	1.57

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sino Biopharmaceutical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SBHMY:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.